SEC Company Response from Protara Therapeutics, Inc. (TARA) (CIK 0001359931) (TARA) — Oct 17, 2014
Protara Therapeutics, Inc. (TARA) (CIK 0001359931)
Date: Oct. 17, 2014 · CIK: 0001359931 · Accession: 0001104659-14-072226
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-198777
Letter
Re: Proteon Therapeutics, Inc.
October 17, 2014
United States Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, DC 20549
Attention: John Krug and Christina De Rosa
Registration Statement on Form S-1
SEC File No. 333-198777
Ladies and Gentlemen:
In connection with the above-captioned Registration Statement, we wish to advise that between October 7, 2014 and the date hereof 2,211 copies of the Preliminary Prospectus dated October 7, 2014 were distributed as follows: 0 to prospective underwriters; 813 to institutional investors; 0 to prospective dealers; 1,398 to individuals; 0 to rating agencies and 0 to others.
We have been informed by the participating underwriters that they will comply with the requirements of Rule 15c2-8 under the Securities Exchange Act of 1934, as amended.
We hereby join in the request of the registrant that the effectiveness of the above-captioned Registration Statement, as amended, be accelerated to 4:00 p.m. Eastern Time, on Tuesday, October 21, 2014, or as soon thereafter as practicable.
[signature page follows]
Very truly yours,
STIFEL, NICOLAUS & COMPANY, INCORPORATED
Show Raw Text
CORRESP 1 filename1.htm October 17, 2014 United States Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, DC 20549 Attention: John Krug and Christina De Rosa Re: Proteon Therapeutics, Inc. Registration Statement on Form S-1 SEC File No. 333-198777 Ladies and Gentlemen: In connection with the above-captioned Registration Statement, we wish to advise that between October 7, 2014 and the date hereof 2,211 copies of the Preliminary Prospectus dated October 7, 2014 were distributed as follows: 0 to prospective underwriters; 813 to institutional investors; 0 to prospective dealers; 1,398 to individuals; 0 to rating agencies and 0 to others. We have been informed by the participating underwriters that they will comply with the requirements of Rule 15c2-8 under the Securities Exchange Act of 1934, as amended. We hereby join in the request of the registrant that the effectiveness of the above-captioned Registration Statement, as amended, be accelerated to 4:00 p.m. Eastern Time, on Tuesday, October 21, 2014, or as soon thereafter as practicable. [signature page follows] Very truly yours, STIFEL, NICOLAUS & COMPANY, INCORPORATED JMP SECURITIES, LLC For themselves and as Representatives of the other Underwriters named in Schedule I of the Underwriting Agreement By: Stifel, Nicolaus & Company, Incorporated By: /s/ Seth Rubin Name: Seth Rubin Title: Managing Director By: JMP Securities, LLC By: /s/ Stephen Ortiz Name: Stephen Ortiz Title: Managing Director Signature Page to Acceleration Request